logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
N

Neeta B. Amin

pfizer usa
H指数:17
被引数:1,415

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Assessment of the Drug-Drug Interaction Potential of Lotiglipron (PF-07081532) with Midazolam, Omeprazole, Dabigatran, Rosuvastatin, and the Oral Contraceptives Levonorgestrel and Ethinyl Estradiol

评估洛替格列酮（PF-07081532）与咪达唑仑、奥美拉唑、达比加群、瑞舒伐他汀以及口服避孕药左炔诺孕酮和炔雌醇的药物相互作用潜力

Journal of Clinical Pharmacology
IF2.3
2026-04-290
OAAI
Cronenberger, Carol; Amin, Neeta B.; Le, Vu H.; Carvajal-Gonzalez, Santos; Ashworth, Amy L.; Yi, Ellen C.; Schuster, Tilman; Zhang, Yizhong; Frederich, Robert C.; Friedman, Gary S.; Wang, Ellen Q.; Tsamandouras, Nikolaos
Human absorption, distribution, metabolism, excretion, and reaction phenotyping of ervogastat (PF-06865571), a diacylglycerol O-acyltransferase 2 inhibitors

厄沃加斯塔特（PF-06865571）的人体吸收、分布、代谢、排泄及反应表型，该药物为二酰基甘油O-酰基转移酶2抑制剂

Drug Metabolism and Disposition
IF4
2026-04-010
OA
Vourvahis, Manoli; Orozco, Christine C.; Tess, David; Zhang, Yizhong; Bauman, Jonathan N.; Gosset, James R.; Amin, Neeta B.; Cerny, Matthew A.
Effect of Varying Degrees of Hepatic Impairment on the Pharmacokinetics of Ervogastat, a Diacylglycerol Acyltransferase 2 (DGAT2) Inhibitor, and Clesacostat, an Acetyl-CoA Carboxylase (ACC) Inhibitor

不同程度肝功能损伤对Ervogastat（一种二酰基甘油酰基转移酶2 [DGAT2] 抑制剂）和Clesacostat（一种乙酰辅酶A羧化酶 [ACC] 抑制剂）药代动力学的影响

JOURNAL OF CLINICAL PHARMACOLOGY
IF2.3
2025-09-010
PRE
Vourvahis, Manoli; Bergman, Arthur J.; Ogden, Adam G.; Hughes, Jim; Gosset, James R.; Kalgutkar, Amit S.; Amin, Neeta B.
Efficacy and safety of ervogastat alone and in combination with clesacostat in patients with biopsy-confirmed metabolic dysfunction-associated steatohepatitis and F2–F3 fibrosis (MIRNA): results from a phase 2, randomised, double-blind, double-dummy study

厄沃格斯特单药及联合克莱萨科斯特治疗活检确诊的代谢功能障碍相关脂肪性肝炎伴F2-F3期肝纤维化患者的疗效与安全性（MIRNA研究）：一项2期、随机、双盲、双模拟试验的结果

The Lancet Gastroenterology & Hepatology
IF0
2025-07-310
PRE
Vincent Wai-Sun Wong; Neeta B Amin; Hirokazu Takahashi; Amanda Darekar; Frank Tacke; Jan Kiszko; Hector Rodriguez; Atsushi Nakajima; Naim Alkhouri; Michael Charlton; Quentin M Anstee
ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials
NATURE MEDICINE
IF50
2021-10-11125
PREAI
Calle, Roberto A.; Amin, Neeta B.; Carvajal-Gonzalez, Santos; Ross, Trenton T.; Bergman, Arthur; Aggarwal, Sudeepta; Crowley, Collin; Rinaldi, Anthony; Mancuso, Jessica; Aggarwal, Naresh; Somayaji, Veena; Inglot, Malgorzata; Tuthill, Theresa A.; Kou, Kou; Boucher, Magalie; Tesz, Greg; Dullea, Robert; Bence, Kendra K.; Kim, Albert M.; Pfefferkorn, Jeffrey A.; Esler, William P.

研究方向

暂未获取到该数据
J
James E. Tisdale
H 指数:37论文数:227被引数:7,776
M
Manoli Vourvahis
H 指数:23论文数:73被引数:1,829
A
Arthur Bergman
H 指数:35论文数:125被引数:5,515
S
Santos Carvajal‐Gonzalez
H 指数:21论文数:58被引数:1,373
C
Collin Crowley
H 指数:7论文数:20被引数:611
Q
Quentin M. Anstee
H 指数:110论文数:607被引数:6.8万
V
Vincent Wai‐Sun Wong
H 指数:142论文数:1,250被引数:9.9万
R
Roberto A. Calle
H 指数:31论文数:118被引数:3,609
A
Albert M. Kim
H 指数:20论文数:46被引数:1,922
R
Robert Frederich
H 指数:35论文数:106被引数:1.4万